ConductScience.org, home

Trial · NCT07892365

The Effect of Chewing Gum on Pain and State Anxiety During Intravenous Blood Sampling

NCT07892365, Not applicable, Completed, Dicle University

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. The Effect of Chewing Gum on Pain and State Anxiety During Intravenous Blood Sampling. Trials, record NCT07892365. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07892365

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
The Effect of Chewing Gum on Pain and State Anxiety During Intravenous Blood Sampling
NCT number
NCT07892365
Status
Completed
Phases
Not applicable
Enrollment
170 participants, actual
Lead sponsor
Dicle University
Conditions
Intravenous Blood Sampling, Pain and Anxiety
Interventions
Chewing gum was done during the intravenous blood draw procedure
First posted
2026-10-23
Last updated
2026-10-27

Source ClinicalTrials.gov

Registered outcomes2

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
Primarypain level-Visual Analog Scale (VAS)Before and immediately after the intravenous blood sampling procedure.
Pain level was assessed using the Visual Analog Scale (VAS) before and after the intravenous blood sampling procedure in both the experimental and control groups. The Visual Analog Scale, used to measure pain intensity, is a one-dimensional scale measuring 0-10 cm (0-100 mm) in length. 0 cm means no pain, 10 cm means unbearable pain. As the score increases, the pain intensity increases. On the scale, 0-4 mm is defined as 'no pain', 4-6 mm is defined as 'slight pain', 7-9 mm is defined as 'moderate pain', 10 mm is defined as 'severe pain'.
Primarystate anxiety level- state anxiety inventory(STAI-I)Before and immediately after the intravenous blood sampling procedure.
State anxiety was assessed using the State Anxiety Inventory (STAI-I) before and after the intravenous blood sampling procedure in both the experimental and control groups. The State Anxiety Inventory (STAI-I) uses a four-point Likert scale (1: Not at all, 2: Somewhat, 3: Very much, 4: Completely). Directly scored items reflect negative emotions, whereas reverse-scored items reflect positive emotions. The State Anxiety Inventory (STAI-I) includes 10 reverse-scored items (items 1, 2, 5, 8, 10, 11, 15, 16, 19, and 20) (140, 148). The total score ranges from 20 to 80, with scores of 20-39 indicating mild anxiety, 40-59 indicating moderate anxiety, and 60-79 indicating high anxiety. Scores of 60 or above are considered indicative of a need for professional support.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07892365

GET https://conductscience.org/api/trials/v1/NCT07892365/registered